Ricardo Calderón-González
- Biotechnology top 5%
- Listeria monocytogenes in Food Safety 10
- Cancer Research and Treatments 3
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 2
-
- Immunotherapy and Immune Responses 10
- Immune Response and Inflammation 4
- interferon and immune responses 2
- Endocrinology top 10%
-
- vaccines and immunoinformatics approaches 7
-
- Viral gastroenteritis research and epidemiology 2
- Co-authors
- Carmen Alvarez‐DomínguezMarco MarradiNikolai PetrovskySoledad PenadésJavier Gómez‐RománJavier FreireJoana Sá‐PessoaAmy Dumigan
- Partner nations
- SpainUnited KingdomAustralia
In The Last Decade
Ricardo Calderón-González
23 papers receiving 378 citations
Peers
Comparison fields: 5 of 64
- Biotechnology 97
- Molecular Medicine 48
- Immunology 169
- Endocrinology 35
- Microbiology 21
Countries citing papers authored by Ricardo Calderón-González
This map shows the geographic impact of Ricardo Calderón-González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo Calderón-González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo Calderón-González more than expected).
Fields of papers citing papers by Ricardo Calderón-González
This network shows the impact of papers produced by Ricardo Calderón-González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo Calderón-González. The network helps show where Ricardo Calderón-González may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ricardo Calderón-González, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 29 | |
| 5 | 2022 | 23 | |
| 6 | 2022 | 25 | |
| 7 | 2021 | 6 | |
| 8 | 2021 | 5 | |
| 9 | 2020 | 5 | |
| 10 | 2017 | 18 | |
| 11 | 2017 | 28 | |
| 12 | 2017 | 14 | |
| 13 | 2016 | 9 | |
| 14 | 2015 | 14 | |
| 15 | 2015 | 65 | |
| 16 | 2015 | 17 | |
| 17 | 2015 | 11 | |
| 18 | 2014 | 26 | |
| 19 | 2013 | 14 | |
| 20 | 2012 | 6 |
About Ricardo Calderón-González
Ricardo Calderón-González is a scholar working on Biotechnology, Immunology and Molecular Medicine, having authored 23 papers that have together received 382 indexed citations. Recurring topics across this work include Listeria monocytogenes in Food Safety (10 papers), Immunotherapy and Immune Responses (10 papers), vaccines and immunoinformatics approaches (7 papers), Immune Response and Inflammation (4 papers), Cancer Research and Treatments (3 papers), Viral gastroenteritis research and epidemiology (2 papers), interferon and immune responses (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Biotechnology (97 citations), Molecular Medicine (48 citations) and Immunology (169 citations). Ricardo Calderón-González has collaborated with scholars based in Spain, United Kingdom and Australia. Frequent co-authors include Carmen Alvarez‐Domínguez, Marco Marradi, Nikolai Petrovsky, Soledad Penadés, Javier Gómez‐Román, Javier Freire, Joana Sá‐Pessoa, Amy Dumigan, José A. Bengoechea and Isabel Garcı́a. Their work appears in journals such as PLoS ONE, Nanoscale and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.